Vineet Laboratories, a company in the Pharmaceuticals industry, reported revenue of ₹14 crore and net profit of ₹0.12 crore for the September 2026 quarter.
Vineet Laboratories (NSE: VINEETLAB) closed at ₹40.06 on 20 Nov 2026. Its market capitalisation is ₹77 crore and it trades at 24.0 times earnings.
Incorporated in 2003, Vineet Laboratories Ltd is in designing, developing, manufacturing of API Intermediates and Bulk Drugs
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.